scispace - formally typeset
Open AccessJournal ArticleDOI

Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases.

Reads0
Chats0
TLDR
This review summarizes and discusses the structure and multiple functions of ACE2 and the relevance of this key enzyme in disease pathogenesis.
Abstract
Angiotensin-converting enzyme 2 (ACE2) is a negative regulator of the renin-angiotensin system, and functions as the key SARS coronavirus receptor and stabilizer of neutral amino acid transporters. ACE2 catalyzes the conversion of angiotensin II to angiotensin 1-7, thereby counterbalancing ACE activity. Accumulating evidence indicates that the enzymatic activity of ACE2 has a protective role in cardiovascular diseases. Loss of ACE2 can be detrimental, as it leads to functional deterioration of the heart and progression of cardiac, renal, and vascular pathologies. Recombinant soluble human ACE2 protein has been demonstrated to exhibit beneficial effects in various animal models, including cardiovascular diseases. ACE2 is a multifunctional enzyme and thus potentially acts on other vasoactive peptides, such as Apelin, a vital regulator of blood pressure and myocardium contractility. In addition, ACE2 is structurally a chimeric protein that has emerged from the duplication of 2 genes: homology with ACE at the carboxypeptidase domain and homology with Collectrin in the transmembrane C-terminal domain. ACE2 has been implicated in the pathology of Hartnup's disease, a disorder of amino acid homeostasis, and, via its function in amino acid transport, it has been recently revealed that ACE2 controls intestinal inflammation and diarrhea, thus regulating the gut microbiome. This review summarizes and discusses the structure and multiple functions of ACE2 and the relevance of this key enzyme in disease pathogenesis.

read more

Citations
More filters
Journal ArticleDOI

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.

TL;DR: It is suggested that ACE2 down-regulation induced by viral invasion may be especially detrimental in people with baseline ACE2 deficiency associated with the above conditions, and recombinant ACE2, angiotensin1-7 and angiotsin II type 1 receptor blockers could be promising therapeutic approaches in patients with SARS-CoV-2 infection.
Journal ArticleDOI

Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets

TL;DR: The ACE2-mediated catabolism of angiotensin II is likely to have a major role in cardiovascular protection, whereas the relevant functions and signalling mechanisms of actions induced by ang Elliotensin 1–7 have not been conclusively determined.
Journal ArticleDOI

Perspective: Vitamin D deficiency and COVID-19 severity - plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis.

TL;DR: SARS‐CoV‐2 coronavirus infection ranges from asymptomatic through to fatal COVID‐19 characterized by a ‘cytokine storm’ and lung failure and Vitamin D deficiency has been postulated as a determinant of severity.
Journal ArticleDOI

ACE2 - from the renin-angiotensin system to gut microbiota and malnutrition.

TL;DR: ACE2 modulates innate immunity and influences the composition of the gut microbiota, which can explain diarrhea and intestinal inflammation observed in Hartnup disorder, Pellagra, or under conditions of severe malnutrition.
Journal ArticleDOI

Epigenetic regulation of angiotensin-converting enzyme 2 (ACE2) by SIRT1 under conditions of cell energy stress

TL;DR: Western blotting and qPCR show that ACE2 expression is increased under conditions of cell stress, including hypoxic conditions, IL (interleukin)-1β treatment and treatment with the AMP mimic AICAR.
References
More filters
Journal ArticleDOI

SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway

TL;DR: It is found that SARS-CoV enters cells via pH- and receptor-dependent endocytosis, and this finding contributes to the understanding of SARS -CoV pathogenesis, providing new information for anti-viral drug research.
Journal ArticleDOI

The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism.

TL;DR: It was found that mean arterial pressure after the administration of apelin, apelin-13, andapelin-36 at a dose of 10 nmol/kg in anaesthetized rats was reduced by 26+/-5, 11+/-4, and 5-/-4 mm Hg, respectively, suggesting that apelin may lower blood pressure via a nitric oxide-dependent mechanism.
Journal ArticleDOI

ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis.

TL;DR: The angiotensin-converting enzyme (ACE)-related carboxypeptidase, ACE2, is a type I integral membrane protein of 805 amino acids that contains one HEXXH + E zinc-binding consensus sequence that offers insights regarding the action of residues involved in catalysis and substrate specificity.
Journal ArticleDOI

Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry

TL;DR: It is found that the spike protein of SARS-CoV (SARS-S) induced TNF-α-converting enzyme (TACE)-dependent shedding of the ACE2 ectodomain, and this data suggest that cellular signals triggered by the interaction of Sars- coV with ACE2 are positively involved in viral entry but lead to tissue damage.
Journal ArticleDOI

Pathophysiology of acute lung injury and the acute respiratory distress syndrome.

TL;DR: This review summarizes the current understanding of the pathophysiology of what is now termed the acute respiratory distress syndrome and its less severe form acute lung injury, with an emphasis on cellular and molecular mechanisms of injury that may represent potential therapeutic targets.
Related Papers (5)